Loading…
Brand of Sodium Chloride
DIORALYTE DOUBLE ACTION RASPBERRY, DIORALYTE RELIEF RASPBERRY & BLACKCURRANT, DIORALYTE RELIEF BLACKCURRANT & RASPBERRY, DIORALYTE RELIEF RASPBERRY is a brand name for Sodium Chloride. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Oral correction of fluid and electrolyte loss in infants aged 3 months upwards, children and adults. Treatment of watery diarrhoea of various aetiologies including gastroenteritis in all age groups from 3 months upwards. Dioralyte Relief is particularly recommended in the case of too loose or frequent stools where it…
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults and children: 5 sachets per day for 3 to 4 days following a loose motion.
Infants from 3 months to one year under medical advice:
In the event of diarrhoea and depending on the extent of dehydration (loss of weight assessed at less than 10%) 150 to 200 ml/kg/24 hours of preparation may be given. • half the volume is to be given during the first 8 hours, and the other half during the next 16 hours.
• in the event of vomiting accompanying the diarrhoea, the amount administered can be divided up (5 to 10 ml every 5 minutes) and this may be gradually increased until the infant can drink normally. Method of Administration Pour the contents of one sachet into a large glass of drinking water (200ml).
Mix well and drink the whole glassful. For infants and where drinking water is not available, the water should be freshly boiled and cooled. The solution should be made up immediately before use.
Other brands of Sodium Chloride in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
The information below lists reported adverse reactions, ranked using the following frequency classification: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Immune system disorders Not known:
Hypersensitivity Reporting of suspected adverse reactions Reporting suspected adverse reaction after authorisation of the medicinal product is important. It allows continued monitoring of the benefit / risk balance of the medicinal product.
uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
For oral administration only. Dioralyte Relief should not be reconstituted in diluents other than water. Each sachet should always be dissolved in 200ml water. Dioralyte Relief should not be administered to infants under 3 months and for those aged 3 months to 1 year, administered under medical advice.
Infants under the age of 2 with diarrhoea should be seen by the physician as soon as possible. If diarrhoea persists unremittingly for longer than 36 hours the patient should be reassessed by the physician. No specific precautions are necessary in the elderly.
However, care should be taken when administering Dioralyte Relief solution in conditions where normal electrolyte balance may be disturbed (such as severe vomiting or diarrhoea). Dioralyte Relief should not be used for self-treatment by patients on low potassium or sodium diets.
The use of Dioralyte Relief in patients with the following conditions should be supervised by a physician: • On low potassium or low sodium diets. This medicine contains 190 mg sodium (main component of cooking/table salt) in each sachet, equivalent to 10 % of the WHO recommended maximum daily dietary intake of 2g of sodium for an adult.
1. Dioralyte Relief should not be used in patients with phenylketonuria. g. intestinal obstruction requiring surgical intervention, cases of severe renal or hepatic impairment.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.